On Physician-Industry Relationships and Unreasonable Standards of Proof for Harm: A Population-Level Bioethics...

Area of Science:

• Medical Ethics
• Public Health Policy
• Epidemiology

Background:

• Physician-industry relationships are common and often extensive.
• A prevalent argument against regulating these relationships demands proof of harm from randomized controlled trials (RCTs).
• This reliance on RCTs for harm evidence undermines the precautionary principle and public health action.

Purpose of the Study:

• To critique the argument that harm from physician-industry relationships must be proven by RCTs.
• To propose alternative evidentiary standards for demonstrating harm.
• To re-establish the justification for public health interventions regarding these relationships.

Main Methods:

• Conceptual analysis of arguments concerning physician-industry relationships.
• Examination of evidentiary standards in public health and epidemiology.
• Critique of the demand for RCT-level evidence of harm.

Main Results:

• The argument requiring RCTs to demonstrate harm from physician-industry relationships is fundamentally deficient.
• This evidentiary standard inappropriately weakens the precautionary principle.
• Alternative, accepted epidemiological and public health standards can effectively demonstrate harm.

Conclusions:

• The current standard of proof for harm from physician-industry relationships is inadequate.
• Public health and epidemiological evidence should be sufficient to justify regulatory action.
• While other reasons may exist to oppose curtailing these relationships, the argument based on RCTs is invalid.